Mild cognitive impairment (MCI) is an early warning sign of Alzheimer’s disease and dementia. Catching it early can make a ...

An oral small molecule from New York-based biotech Oligomerix curbed the tangling of tau protein in the brains of mice that ...

The research findings primarily focus on individuals with a sleep disorder but may have broader implications. A recent study ...

Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...

Last June retired pediatrician Dr. Ora Wells was diagnosed with Alzheimer’s Disease. At 2 p.m., Sunday, March 30 the ...

There is an inverse bidirectional association between cancer and dementia, a relationship that holds across cancer and dementia subtypes.

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...

Since Alzheimer’s advanced stage has no cure right now, the entire focus of Zentara is on prevention. For this purpose, it has identified two goals: make early Alzheimer’s diagnosis cheaper and give ...

Medicare covers part-time home healthcare for qualifying individuals with dementia. Learn who is eligible, what services Medicare covers, and more.

A new international study has identified key genetic factors that may protect against Alzheimer’s disease (AD), offering ...

Chicago area scientists have identified the genes that drive the process of Alzheimer’s disease and are working to make the drug Lecanemab even better by identifying which genes are active ...